The ingredient

The best of the fruit, the precision of the laboratory.

GRANADOL® is an ingredient made from selected parts of the pomegranate, invented and developed by Laboratoires POMEGA in Haute-Savoie, France, after four years of research.

Whole and halved ripe pomegranates showing their red seeds
Key figures: 4 years of research, 200 mg per tablet in POMEGA FLEX Dog, European patent cleared for grant, 100% made in France

From the fruit to a standardised ingredient

Origin

The pomegranate, a fruit valued for centuries, carefully selected.

GRANADOL® powder, a fine pink-beige powder

Process

A proprietary manufacturing process, designed by pharmacists and produced in France.

A rich natural profile

GRANADOL® preserves the diversity of compounds naturally present in the pomegranate. Its key quality parameters are checked on every batch by an independent laboratory.

Confidential by design

The exact composition of GRANADOL® and its manufacturing process are protected by patent application and kept confidential.

Why joints need more than one approach

Diagram of the vicious circle of joint discomfort: discomfort leads to less activity, stiffness, weakness and weight gain, which bring back discomfort. GRANADOL® sits at the centre, designed to act on both sides of the circle.

GRANADOL® was designed to act on both sides of this circle at once, rather than on a single mechanism.

Invented. Industrialised. Launched.

Three milestones: invented, European patent cleared for grant; industrialised, made in France, lot 2601; launched in POMEGA FLEX Dog in November 2026

European patent cleared for grant. Produced industrially in France. On the market since November 2026 in POMEGA FLEX Dog.

Detailed data available to partners under NDA.

A different source in joint care

Most joint-care supplements are built on the same few families of ingredients. GRANADOL® comes from somewhere else.

GRANADOL®

  • From pomegranate, a new source in joint care
  • Invented and made in France
  • European patent cleared for grant

The usual joint-care ingredients

  • Green-lipped mussel — marine origin
  • Collagen — animal origin
  • Glucosamine, chondroitin, MSM — widely used for decades
  • Other plant extracts — various sources

Our journey

Timeline with a European patent cleared for grant banner: 2022 research begins; 2023 Laboratoires POMEGA founded; 2024–2026 from laboratory to industrial scale; September 2026 lot 2601, first industrial batch; November 2026 POMEGA FLEX Dog on the market; 2027 POMEGA FLEX Horse; next, POMEGA FLEX Cat

The best of the fruit, the precision of the laboratory.

Evidence before promises

  • Produced in France, with a French manufacturing partner
  • Every batch analysed by an independent laboratory, certificate of analysis provided
  • Notified in the EU Register of feed materials
  • Registered feed business operator with the French authorities (DDPP Haute-Savoie), HACCP
Lot 2601 of GRANADOL®, our first industrial batch
Lot 2601, our first industrial batch of GRANADOL®, after laboratory, pilot and scale-up batches. Produced for the commercial launch, September 2026.

What it supports

Supports joint mobility and flexibility.